These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22472322)

  • 1. Reversal of pulmonary vascular remodeling in pulmonary hypertensive rats.
    Sluiter I; van Heijst A; Haasdijk R; Kempen MB; Boerema-de Munck A; Reiss I; Tibboel D; Rottier RJ
    Exp Mol Pathol; 2012 Aug; 93(1):66-73. PubMed ID: 22472322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation.
    de Frutos S; Spangler R; Alò D; Bosc LV
    J Biol Chem; 2007 May; 282(20):15081-9. PubMed ID: 17403661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing.
    Bonnet S; Dubuis E; Vandier C; Martin S; Marthan R; Savineau JP
    Cardiovasc Res; 2002 Mar; 53(4):1019-28. PubMed ID: 11922912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension.
    Chassagne C; Eddahibi S; Adamy C; Rideau D; Marotte F; Dubois-Randé JL; Adnot S; Samuel JL; Teiger E
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):323-32. PubMed ID: 10696069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension.
    Chu X; Kheirollahi V; Lingampally A; Chelladurai P; Valasarajan C; Vazquez-Armendariz AI; Hadzic S; Khadim A; Pak O; Rivetti S; Wilhelm J; Bartkuhn M; Crnkovic S; Moiseenko A; Heiner M; Kraut S; Atefi LS; Koepke J; Valente G; Ruppert C; Braun T; Samakovlis C; Alexopoulos I; Looso M; Chao CM; Herold S; Seeger W; Kwapiszewska G; Huang X; Zhang JS; Pullamsetti SS; Weissmann N; Li X; El Agha E; Bellusci S
    Circ Res; 2024 May; 134(11):e133-e149. PubMed ID: 38639105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGMP-dependent protein kinase Iα transfection inhibits hypoxia-induced migration, phenotype modulation and annexins A1 expression in human pulmonary artery smooth muscle cells.
    Yi B; Cui J; Ning J; Gu J; Wang G; Bai L; Qian G; Lu K
    Biochem Biophys Res Commun; 2012 Feb; 418(4):598-602. PubMed ID: 22293199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
    Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
    Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of early digoxin treatment on hypoxia-induced pulmonary artery hypertension].
    Yan G; Hu S; Wang Q; Wang D; Wang J; Qiao Y; Tang C; Ma G; Gu Y
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):139-43. PubMed ID: 24721356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 improves cardiovascular function and survival in flow-induced pulmonary hypertension.
    Roan JN; Hsu CH; Fang SY; Tsai HW; Luo CY; Huang CC; Lam CF
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1661-1669.e4. PubMed ID: 29249493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of docosahexaenoic acid on hypoxia-induced pulmonary arterial hypertension].
    Chen R; Liu P; Yan J; Gu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Feb; 37(2):109-12. PubMed ID: 24796591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally.
    Cahill E; Rowan SC; Sands M; Banahan M; Ryan D; Howell K; McLoughlin P
    Exp Physiol; 2012 Jun; 97(6):796-806. PubMed ID: 22366565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.
    Thorsen LB; Eskildsen-Helmond Y; Zibrandtsen H; Stasch JP; Simonsen U; Laursen BE
    Eur J Pharmacol; 2010 Nov; 647(1-3):147-54. PubMed ID: 20828552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
    Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of endothelin-1 in rats developing hypobaric hypoxia-induced pulmonary hypertension.
    Nakanishi K; Tajima F; Nakata Y; Osada H; Tachibana S; Kawai T; Torikata C; Suga T; Takishima K; Aurues T; Ikeda T
    Lab Invest; 1999 Nov; 79(11):1347-57. PubMed ID: 10576205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell stabilization with sodium cromoglycate modulates pulmonary vessel wall remodeling during four-day hypoxia in rats.
    Novotný T; Krejčí J; Malíková J; Švehlík V; Wasserbauer R; Uhlík J; Vajner L
    Exp Lung Res; 2015 Jun; 41(5):283-92. PubMed ID: 26052828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension.
    Hayashida K; Fujita J; Miyake Y; Kawada H; Ando K; Ogawa S; Fukuda K
    Chest; 2005 May; 127(5):1793-8. PubMed ID: 15888860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.